4502Takeda Pharmaceutical Co., Ltd.
+1.2% today · +56.0% over a year
No score: too little data.
Stability: among the best of its peers. Dividend yield 3.17%.
Over the past 12 months the price changed by +56.0%, with an annualised volatility of 22% and a largest fall of 19%. The dividend has been raised 16 years in a row.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Volatility (1 y)supports the score · better than 91% of peers
- Max drawdown (3 y)supports the score · better than 95% of peers
- Betasupports the score · better than 94% of peers
Red flags and notes
No red flagsNone of our published warning rules is triggered right now.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Dividends
- Dividend yield
- 3.17%
- 5-year dividend growth (per year)
- 2.3%
- Years of dividend growth
- 16
Returns and risk
- 1 day
- +1.2%
- 1 month
- +11.2%
- 1 year
- +56.0%
- Volatility, 1 yr
- 22.2%
- Max drawdown, 1 yr
- −19.4%
- Beta
- 0.35
Returns are price changes from end-of-day prices, without dividends.
Similar companies
Same sector, closest in price swings over the past year.
| LONNLonza Group AG | —/10 | 0.8% | 11.6% |
|---|---|---|---|
| SNYSanofi | 7/10 | 5.0% | −12.7% |
| SANSanofi SA | 8/10 | 5.5% | −8.6% |
| 1099Sinopharm Group | —/10 | 4.9% | −13.3% |
| TAKTakeda Pharmaceutical Co Ltd | —/10 | 0.0% | 42.9% |
| NOVNNovartis AG | 10/10 | 2.9% | 34.7% |
| RORoche Holding AG (bearer shares) | —/10 | 2.7% | 52.9% |
| GSKGSK plc | 10/10 | 3.7% | 11.4% |
News and filings
- TAKEDA PHARMACEUTICAL CO LTD: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 14 Sep 2026
- TAKEDA PHARMACEUTICAL CO LTD: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 29 Aug 2026
- TAKEDA PHARMACEUTICAL CO LTD: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 6 Aug 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
No published ratings in the last 12 months.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.